Skip to main content
SpringerLink
Log in

No change in volume of ARB prescriptions in USA after recalls

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Desai RJ, et al. Changes in Utilization of Generic Angiotensin Receptor Blockers Following Product Recalls in the United States. JAMA: the Journal of the American Medical Association : 7 Jan 2020. Available from: URL: http://dx.doi.org/10.1001/jama.2019.17521

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

No change in volume of ARB prescriptions in USA after recalls. Reactions Weekly 1787, 8 (2020). https://doi.org/10.1007/s40278-020-73646-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-73646-0

Search

Navigation